Regulatory Trends in AI-enabled SaMDs
FDA authorisations of AI-enabled software as medical devices (SaMDs) have increased significantly. Over 50% of FDA authorisations have occurred since 2022 with the majority (76%)…
Read MoreTechnology Insight
Existing Medicines, New Possibilities – How Graph Intelligence is Accelerating Rare Disease Discovery
Gamification Techniques Healthcare Providers Can Learn from These 4 Games
Pharmacovigilance’s Productivity Problem: The Workflows Overlooked by Digital Investment
Modernizing Healthcare Data Exchange for the AI Era
Frontline Productivity: A Strategic Imperative for NHS Leaders
Drug Safety in the Modern Age: Is it Time for a Larger-scale Revamp of Adverse Event Case Processing?
RPM Programs: What It Takes for Health Systems to Scale Successfully
Connecting Access and Throughput as a Single System
Huawei Xinghe Intelligent High-Quality Hospital Network: Empowering Global Smart Healthcare Development
The global healthcare industry is fully advancing into a new era of intelligent digital transformation. Mobile ward rounds, remote consultation, high-definition medical image access, and…